The Latest Breaking News on Pharma

Amgen (AMGN) is scheduled to report its third-quarter earnings soon, with Wall Street analysts expecting year-over-year improvements in revenue. However, its earnings are expected to miss the consensus estimate. Moreover, the company completed the acquisition of Horizon Therapeutics earlier this month. Considering these factors, is the stock a buy or…

Community pharmacies across Scotland are being provided with a drug which can reverse overdoses.

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

The U.S. Customs and Border Protection has announced a new government-wide strategy that will target not only fentanyl but precursor materials used to make the synthetic opioid

The pharmaceutical sector is expected to thrive due to the rising demand for advanced medicines to treat lifestyle diseases and its increasing ability to meet quality treatment needs thanks to technological advancements. Therefore, it could be wise to add fundamentally strong pharma stocks Amneal Pharmaceuticals (AMRX), Dr. Reddy’s Laboratories (RDY),…

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. Thus, it would be prudent to buy pharma stocks, Sanofi (SNY), Johnson & Johnson (JNJ) and AstraZeneca PLC (AZN). Read on.

350 people will be laid off, many of them at Horizon’s U.S. base in Deerfield.

The healthcare industry is well-positioned for expansion due to rising healthcare expenditures and growing demand for quality treatment. Given the industry’s solid long-term prospects, investors might consider buying quality stocks Cigna (CI), UnitedHealth Group (UNH) and Elevance Health (ELV). Read on….

Laura Bray couldn't watch her 9-year-old's leukemia go untreated. She started campaigning to fix a broken system and get patients the treatments they need in the face of drug shortages.

Some state and local governments have started tapping in to opioid settlement funds for law enforcement expenses. Many argue it should go toward treating addiction instead.

The biotech industry's upward momentum is underpinned by the growth of personalized medicine, orphan drugs, innovative biotech tools, and robust government backing. Hence, revolutionary biotech stocks Equillium (EQ), Protalix BioTherapeutics (PLX), and Incyte Corporation (INCY) could make ideal additions to your portfolio at present. Read more….